|Bid||88.83 x 1100|
|Ask||103.00 x 800|
|Day's Range||88.01 - 90.30|
|52 Week Range||82.12 - 121.98|
|Beta (3Y Monthly)||1.49|
|PE Ratio (TTM)||37.26|
|Earnings Date||Jul 30, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||113.33|
PRA Health Sciences, Inc. is pleased to announce it has received an array of awards and recognition during the first months of 2019. This is the seventh consecutive year that the company has won this prestigious industry award. Clinical Researcher of the Year – The Americas is a real-world competition that recognizes the talent and passion of industry and academic researchers and is considered a key barometer of quality standards in the clinical research organization (CRO) industry.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
PRA Health Sciences Inc NASDAQ/NGS:PRAHView full report here! Summary * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for PRAH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting PRAH. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $3.06 billion over the last one-month into ETFs that hold PRAH are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Medical technology stocks hit record highs last year and are rising in 2019. Six of the fastest growing among them have tacked on double-digit earnings growth for several years.
PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 3.77% and -1.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
The Raleigh, North Carolina-based company said it had profit of 66 cents per share. Earnings, adjusted for amortization costs and stock option expense, came to $1.10 per share. The results surpassed Wall ...
Net new business of $664.6 million; Net book-to-bill of 1.27$722.0 million of total revenue; representing 2.9% growth at actual foreign exchange rates and 4.4% growth on a.
PRA Health Sciences (PRAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]
PRA Health Sciences, Inc. (NASDAQ:PRAH), which is in the life sciences business, and is based in United States, saw a decent share price growth in the teens level on the NASDAQGS over the las...
RALEIGH, N.C., April 09, 2019 -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its first quarter 2019 results after the market closes on Wednesday, May 1, 2019. The.
RALEIGH, N.C., April 08, 2019 -- PRA Health Sciences, Inc. is pleased to announce it has won a 2019 CRO Leadership Award in the following categories: Capabilities.
PRA Health Sciences (PRAH) could produce exceptional returns because of its solid growth attributes.